These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 358484

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prostaglandin inhibitory effects of polyphloretin phosphate.
    Fredholm B.
    Acta Biol Med Ger; 1976; 35(8-9):1233-9. PubMed ID: 827172
    [No Abstract] [Full Text] [Related]

  • 24. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV, Gorman RR.
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The character of the antagonism by polyphloretin phosphate of contractions to prostaglandins E1 and F 2alpha in guinea-pig ileum.
    Petkov V, Radomirov R, Petkov O, Todorov S.
    J Pharm Pharmacol; 1978 Aug; 30(8):491-4. PubMed ID: 28396
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [Abstract] [Full Text] [Related]

  • 31. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL, Blass KE, Förster W.
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ, Hamid S, Lidbury P, Rosam AC.
    Adv Exp Med Biol; 1985 May; 192():109-25. PubMed ID: 2871707
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Responses of isolated dog cerebral and peripheral arteries to prostaglandins after application of aspirin and polyphloretin phosphate.
    Toda N, Miyazaki M.
    Stroke; 1978 May; 9(5):490-8. PubMed ID: 705832
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ, Moncada S, Mullane K, Vane JR.
    Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
    [Abstract] [Full Text] [Related]

  • 39. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.